Literature DB >> 34546237

A multiplexed ion-exchange membrane-based miRNA (MIX·miR) detection platform for rapid diagnosis of myocardial infarction.

Xiang Ren1, Bradley W Ellis1, George Ronan1, Stuart Ryan Blood2, Cameron DeShetler2, Satyajyoti Senapati2, Keith L March3, Eileen Handberg3, David Anderson3, Carl Pepine3, Hsueh-Chia Chang1,2, Pinar Zorlutuna1,2.   

Abstract

Micro RNAs (miRNAs) have shown great potential as rapid and discriminating biomarkers for acute myocardial infarction (AMI) diagnosis. We have developed a multiplexed ion-exchange membrane-based miRNA (MIX·miR) preconcentration/sensing amplification-free platform for quantifying in parallel a panel of miRNAs, including miR-1, miR-208b, and miR-499, from the same plasma samples from: 1) reference subjects with no evident coronary artery disease (NCAD); 2) subjects with stable coronary artery disease (CAD); and 3) subjects experiencing ST-elevation myocardial infarction (STEMI) prior to (STEMI-pre) and following (STEMI-PCI) percutaneous coronary intervention. The picomolar limit of detection from raw plasma and 3-decade dynamic range of MIX·miR permits detection of the miRNA panel in untreated samples from disease patients and its precise standard curve, provided by large 0.1 to 1 V signals and eliminates individual sensor calibration. The use of molecular concentration feature reduces the assay time to less than 30 minutes and increases the detection sensitivity by bringing all targets close to the sensors. miR-1 was low for NCAD patients but more than one order of magnitude above the normal value for all samples from three categories (CAD, STEMI-pre, and STEMI-PCI) of patients with CAD. In fact, miR-1 expression levels of stable CAD, STEMI-pre and STEMI-PCI are each more than 10-fold higher than the previous class, in that order, well above the 95% confidence level of MIX·miR. Its overexpression estimate is significantly higher than the PCR benchmark. This suggests that, in contrast to protein biomarkers of myocardial injury, miR-1 appears to differentiate ischemia from both reperfusion injury and non-AMI CAD patients. The battery-operated MIX·miR can be a portable and low-cost AMI diagnostic device, particularly useful in settings where cardiac catheterization is not readily available to determine the status of coronary reperfusion.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34546237      PMCID: PMC9115728          DOI: 10.1039/d1lc00685a

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   7.517


  54 in total

Review 1.  Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis.

Authors:  Nobuyoshi Kosaka; Haruhisa Iguchi; Takahiro Ochiya
Journal:  Cancer Sci       Date:  2010-07-07       Impact factor: 6.716

2.  miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1.

Authors:  Jian-Xun Wang; Jian-Qin Jiao; Qian Li; Bo Long; Kun Wang; Jin-Ping Liu; Yan-Rui Li; Pei-Feng Li
Journal:  Nat Med       Date:  2010-12-26       Impact factor: 53.440

Review 3.  Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction).

Authors:  Dimitry A Chistiakov; Alexander N Orekhov; Yuri V Bobryshev
Journal:  J Mol Cell Cardiol       Date:  2016-04-04       Impact factor: 5.000

4.  Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples.

Authors:  Olof Gidlöf; Patrik Andersson; Jesper van der Pals; Matthias Götberg; David Erlinge
Journal:  Cardiology       Date:  2011-06-24       Impact factor: 1.869

5.  Transcoronary concentration gradients of circulating microRNAs.

Authors:  Salvatore De Rosa; Stephan Fichtlscherer; Ralf Lehmann; Birgit Assmus; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

6.  Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction.

Authors:  Junjie Xiao; Bo Shen; Jin Li; Dongcao Lv; Yingying Zhao; Fei Wang; Jiahong Xu
Journal:  Int J Clin Exp Med       Date:  2014-01-15

7.  Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction.

Authors:  Fabiola Olivieri; Roberto Antonicelli; Maria Lorenzi; Yuri D'Alessandra; Raffaella Lazzarini; Gabriele Santini; Liana Spazzafumo; Rosamaria Lisa; Lucia La Sala; Roberta Galeazzi; Rina Recchioni; Roberto Testa; Giulio Pompilio; Maurizio C Capogrossi; Antonio Domenico Procopio
Journal:  Int J Cardiol       Date:  2012-02-12       Impact factor: 4.164

8.  Circulating miR-208b: A Potentially Sensitive and Reliable Biomarker for the Diagnosis and Prognosis of Acute Myocardial Infarction.

Authors:  Xiaoxiao Liu; Ling Yuan; Fang Chen; Lizhu Zhang; Xi Chen; Chengjian Yang; Zhijun Han
Journal:  Clin Lab       Date:  2017-01-01       Impact factor: 1.138

9.  A multiplexed immuno-sensor for on-line and automated monitoring of tissue culture protein biomarkers.

Authors:  Zeinab Ramshani; Fei Fan; Alicia Wei; Miguel Romanello-Giroud-Joaquim; Chang-Hyun Gil; Matt George; Mervin C Yoder; Donny Hanjaya-Putra; Satyajyoti Senapati; Hsueh-Chia Chang
Journal:  Talanta       Date:  2020-12-23       Impact factor: 6.556

View more
  4 in total

Review 1.  Myocardial infarction from a tissue engineering and regenerative medicine point of view: A comprehensive review on models and treatments.

Authors:  Gozde Basara; Gokhan Bahcecioglu; S Gulberk Ozcebe; Bradley W Ellis; George Ronan; Pinar Zorlutuna
Journal:  Biophys Rev (Melville)       Date:  2022-08-30

2.  Human Heart Anoxia and Reperfusion Tissue (HEART) Model for the Rapid Study of Exosome Bound miRNA Expression As Biomarkers for Myocardial Infarction.

Authors:  Bradley W Ellis; George Ronan; Xiang Ren; Gokhan Bahcecioglu; Satyajyoti Senapati; David Anderson; Eileen Handberg; Keith L March; Hsueh-Chia Chang; Pinar Zorlutuna
Journal:  Small       Date:  2022-06-07       Impact factor: 15.153

Review 3.  Towards Multiplexed and Multimodal Biosensor Platforms in Real-Time Monitoring of Metabolic Disorders.

Authors:  Sung Sik Chu; Hung Anh Nguyen; Jimmy Zhang; Shawana Tabassum; Hung Cao
Journal:  Sensors (Basel)       Date:  2022-07-12       Impact factor: 3.847

Review 4.  A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research.

Authors:  Cameron Brown; Michael Mantzaris; Elpiniki Nicolaou; Georgia Karanasiou; Elisavet Papageorgiou; Giuseppe Curigliano; Daniela Cardinale; Gerasimos Filippatos; Nikolaos Memos; Katerina K Naka; Andri Papakostantinou; Paris Vogazianos; Erietta Ioulianou; Christos Shammas; Anastasia Constantinidou; Federica Tozzi; Dimitrios I Fotiadis; Athos Antoniades
Journal:  Cardiooncology       Date:  2022-09-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.